Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Depreciation & Amortization (CF): 2020-2024

Historic Depreciation & Amortization (CF) for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to $118,877.

  • Cardiol Therapeutics' Depreciation & Amortization (CF) fell 6.60% to $25,582 in Q3 2022 from the same period last year, while for Sep 2022 it was $104,223, marking a year-over-year change of. This contributed to the annual value of $118,877 for FY2024, which is 2.15% down from last year.
  • Latest data reveals that Cardiol Therapeutics reported Depreciation & Amortization (CF) of $118,877 as of FY2024, which was down 2.15% from $121,485 recorded in FY2023.
  • Cardiol Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $121,485 during FY2023, with a 5-year trough of $104,194 in FY2022.
  • In the last 3 years, Cardiol Therapeutics' Depreciation & Amortization (CF) had a median value of $118,877 in 2024 and averaged $114,852.
  • Per our database at Business Quant, Cardiol Therapeutics' Depreciation & Amortization (CF) fell by 3.97% in 2022 and then grew by 16.59% in 2023.
  • Over the past 5 years, Cardiol Therapeutics' Depreciation & Amortization (CF) (MRY) stood at $108,310 in 2020, then increased by 0.18% to $108,504 in 2021, then fell by 3.97% to $104,194 in 2022, then increased by 16.59% to $121,485 in 2023, then decreased by 2.15% to $118,877 in 2024.
  • Its last three reported values are $118,877 in FY2024, $121,485 for FY2023, and $104,194 during FY2022.